New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) T... ( Study Confirms Role of AMBIEN CR ...)

HOME >> MEDICINE >> TECHNOLOGY

New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV

Date:10/24/2007

Study Confirms Role of AMBIEN CR in Effectively Managing Insomnia to

Improve Quantity and Quality of Work Performance

BRIDGEWATER, N.J., Oct. 24 /PRNewswire-FirstCall/ -- Sanofi-aventis today announced results from a new study that showed patients with chronic insomnia who were treated with 12.5 mg of AMBIEN CR(R) (zolpidem tartrate extended- release) tablets CIV experienced significant improvements in two key parameters of work performance - output and time management - over a period of 12 weeks compared with patients taking placebo. Patients with chronic insomnia can have a higher frequency of work-related problems including absenteeism, an increased rate of accidents, difficulty performing duties and less job satisfaction. These results, which were part of a larger study that evaluated the efficacy and safety of AMBIEN CR when taken as needed, were recently presented at the 20th Annual U.S. Psychiatric and Mental Health Congress in Orlando, Florida.

The multi-center, phase IIIb, randomized, double-blind study included 728 patients with chronic primary insomnia (478 treated with AMBIEN CR and 250 treated with placebo). Treatment with AMBIEN CR showed significantly higher improvement from baseline in work tasks at week 12 in Work Limitation Questionnaire (WLQ) for both Time Management Scale (- 7.39 difference; p < 0.001) and the Output Scale (- 4.8 difference; p = 0.0076) compared to placebo, which was confirmed by an effect size analysis. The majority of adverse events experienced by patients in the study were mild to moderate in intensity, and the most frequently reported adverse events by participants include headache, anxiety and somnolence.

"These new data add to the growing body of evidence that shows that the treatment of chronic insomnia can improve next day functioning," said Milton Erman, MD, chief medical officer, Avastra USA, and clinical professor of psychiatry, UCSD School of Medicine. "This study demonstrates
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide
2. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
3. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
4. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
10. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
11. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine

Post Your Comments:

(Date:5/24/2013)... 24, 2013 The potential of ... delivery of therapeutic agents has been receiving undeniable attention ... showing significant promise. The crucial formulation considerations for orally ... play a major role in the efficiency of pulmonary ... development of new formulation techniques and devices in recent ...

(Date:5/23/2013)... y PARÍS, 24 de mayo de 2013 ... un destacado desarrollador y fabricante de herramientas de ... diagnosis y tratamiento de la enfermedad vascular periférica ... ensayo ADVISE ( Ad enosine V asodilator ... valuation) II durante la sesión de ensayo clínico ...

(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering. In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering. A portion of the proceeds will ...

Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6 Nephros Announces Completion of Rights Offering 2 Nephros Announces Completion of Rights Offering 3 Nephros Announces Completion of Rights Offering 4

[0] Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany [0] Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 [0] Nephros Announces Completion of Rights Offering

... NEW YORK, Dec. 9, 2010 Reportlinker.com announces ... in its catalogue: Allergic ... 2017 http://www.reportlinker.com/p0336527/Allergic-Conjunctivitis---Pipeline-Assessment-and-Market-Forecasts-to-2017.html ... Market Forecasts to 2017 Summary ...

... The Pharmaceutical Industry Labor-Management Association (PILMA) today ... the issue of creating high-quality jobs in the life ... by Dave Holveck, CEO of Endo Pharmaceuticals, to advance ... leads to job growth. Senator Casey knows ...

Cached Medicine Technology:Reportlinker Adds Allergic Conjunctivitis - Pipeline Assessment and Market Forecasts to 2017 2 Reportlinker Adds Allergic Conjunctivitis - Pipeline Assessment and Market Forecasts to 2017 3 Pharmaceutical Industry Labor-Management Association Applauds Senator Casey (D-PA) for Biopharmaceutical Job Creation Efforts 2

Reportlinker Adds Allergic Conjunctivitis - Pipeline Assessment and Market Forecasts to 2017 Pharmaceutical Industry Labor-Management Association Applauds Senator Casey (D-PA) for Biopharmaceutical Job Creation Efforts

(Date:5/26/2013)... May 26, 2013 Learning proper oral care ... healthy teeth and gums. By making this practice a habit, ... into their adulthood. , My Clean Teeth is a new, ... the importance of good oral hygiene. From her experience as ... book explains tips and techniques to encourage kids to learn ...

(Date:5/26/2013)... Illinois (PRWEB) May 26, 2013 ... living community, is celebrating National Senior Health and Fitness ... from 2 to 4 p.m. on Tuesday, May 29. ... Blvd. in O'Fallon, Illinois, serves older adults of all ... to maintain their independence. , A Walgreens representative will ...

(Date:5/26/2013)... May 26, 2013 Veteran airline captain ... will speak to hospital leaders about surviving the health ... taking place at the Hyatt Regency Resort & Spa ... MediServe Conference is designed for administrators leading ... Mediware Company, has delivered software solutions to the rehabilitation ...

(Date:5/26/2013)... May 26, 2013 Ayurveda Panama is ... in Sanscrit "knowledge or wisdom of life." The Escuela ... in Spanish via the Distance Learning program in Panama ... (Abhyanga, Shirodhara, Svedanai), Ayurvedic Health Practitioner and Clinical Ayurvedic ... is designed for the student wishing to integrate their ...

(Date:5/26/2013)... 26, 2013 Pain Free Living web: ... excited to release a new line of copper ... bursitis. This new line of copper bracelets for pain ... woven to form a trinity of metals generating a ... relief in seconds with these handmade copper bracelets in ...

Breaking Medicine News(10 mins):Health News:Author LizB on Talking Teeth with Tots: New Kid’s Book for Daily Dental Care 2 Health News:St. Louis Metro East Affordable Assisted Living Community to Host Senior Health and Fitness Day 2 Health News:What Can Hospital Leaders Learn from a Flock of Geese? 2 Health News:What Can Hospital Leaders Learn from a Flock of Geese? 3 Health News:Ayurveda Panama Program Offered by Escuela Ayurveda de California in June, 2013 2 Health News:Superior Magnetics announces copper bracelet for pain relief of arthritis 2

[0] Author LizB on Talking Teeth with Tots: New Kid’s Book for Daily Dental Care [0] St. Louis Metro East Affordable Assisted Living Community to Host Senior Health and Fitness Day [0] What Can Hospital Leaders Learn from a Flock of Geese?[0] Ayurveda Panama Program Offered by Escuela Ayurveda de California in June, 2013 [0] Superior Magnetics announces copper bracelet for pain relief of arthritis

... hearing loss in laboratory animals, according to two new ... of a pill that could stave off noise-induced and ... findings will be reported Wednesday at the Association for ... author Colleen Le Prell, Ph.D., a researcher at the ...

... National Head Start Association (NHSA) issued the following statement ... is the director of the Albina Head Start program ... be created -- and more than 200,000 existing jobs ... has signed into law the economic recovery package containing ...

... Quarterly EPS of $0.39, Total Revenues of $109.1 Million ... Total Revenues by 17% -- Company Generates $178.3 Million ... Gen-Probe Incorporated (Nasdaq: GPRO ... quarter and full year ended December 31, 2008, including ...

... MADISON, Wis., Feb. 17 /PRNewswire-FirstCall/ -- Cogdell ... appointment of Roger Herritz as President of the Midwest ... Inpatient Project Delivery for the Company,s wholly owned subsidiary, ... the Company,s Madison office, Mr. Herritz will be responsible ...

... Lingering physical effects of cancer a likely cause, finds study, ... fighting cancer wasn,t hard enough, a new Dutch study concludes ... be able to find a job. , The meta-analysis of ... those who,d battled cancer were out of work vs. 15.2 ...

... sent today to,President Obama and members of the ... leadership of Congress on the enactment of,the American ... the first time,provides financial incentives to physicians who ... improve both the quality and cost-,effectiveness of patient ...

Vitamin supplements may protect against noise-induced hearing loss NHSA: President Obama, Congress Deserve High Praise for $2.1 Billion in Recovery Package for Head Start Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 Cogdell Spencer Names Herritz and Wolters to Key Leadership Positions Within Erdman One in Three Cancer Survivors on Unemployment Line Allscripts Applauds Economic Stimulus Incentives Rewarding Physicians for Using Electronic Health Records

The MACS VA_500 (variable atmosphere) is primarily for the study and isolation of microaerophilic organisms,including Campylobacter spp,Helicobacter pylori and other similarly fastdious organisms....

... an electrical power supply, MERKUR offers a broad ... a gas spring for ease of operation. For ... a foot pedal hydraulic system. Thanks to its ... anytime in a highly mobile and flexible manner. ...

... table MARS Enduro is the ideal ... are required before, during or directly ... motorised longitudinal adjustment and the filigreed ... conditions in examination, induction and operating ...

... Top Rotation provides uncommon bi-directional flexibility, ... Hercules 6700B eliminates any conflicts between ... while providing ample leg room for ... procedures. Removable back and leg sections ...

Medicine Products:

VA-500 Merkur Mars Enduro Hercules 6700B